News and Trends 26 Sep 2022 TAU Systems to build new generation of compact particle accelerators after $15M investment …size and high cost, access for engineers and biotech professionals is severely limited. The laser-driven particle accelerators and X-ray free-electron lasers (XFEL) developed by TAU Systems will give access to… September 26, 2022 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
In Depth 25 Mar 2024 Beyond Wegovy: Could Novo Nordisk’s new experimental weight loss pill be even better? …were reported. A mid-stage trial for amycretin will begin in the second half of this year, according to Novo Nordisk, with results expected in early 2026. Novo Nordisk’s growing obesity… March 25, 2024 - 4 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 19 Dec 2024 After decades of stagnation, is Japan’s biopharma industry set for an upswing? …same time, with the dotcom bubble bursting in the early 2000s, the Japanese startup biotech industry struggled to take off,” said Westblad. “It was seen as very risky and had… December 19, 2024 - 12 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Best in Biotech 20 Feb 2025 3 promising biotech approaches to treat Hunter syndrome, a rare genetic disorder …result in a deficiency or a complete absence of I2S, in turn causing an abnormal accumulation of GAGs in cells. Currently, there is no cure for Hunter syndrome. But biotechs… February 20, 2025 - 10 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Startup Scout 7 Feb 2020 Sigrid Therapeutics Prevents Type 2 Diabetes Using Silica Powder in the Gut In Stockholm, Sweden, Sigrid Therapeutics is developing an ingestible silica powder that can treat type 2 diabetes and obesity without being absorbed in the gut. Mission: To produce the first… February 7, 2020 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
More News! 19 Jan 2017 I heard about these Hot Topics at JPM: Devices, Politics & Personalities Last week, I had the pleasure of attending one of the smaller satellite events of the JP Morgan biotech conference. Here are some of the day’s themes. The JP Morgan… January 19, 2017 - 4 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 18 Nov 2022 Novavax’ COVID-19 vaccine gets expanded authorization for booster in adults …grades) of solicited adverse events generally increased, with most events being mild to moderate in severity. Novavax’ vaccine has been authorized as a heterologous and homologous booster in the U.S.,… November 18, 2022 - 2 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
News and Trends 3 Jul 2017 From Rockets to DNA – From SpaceX to CRISPR …the case of CRISPR, off-target events are minimized, whilst on-target events increase dramatically One major challenge is to get people to move away from outdated processes. Scientists are notoriously dogmatic… July 3, 2017 - 6 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
In Depth 13 Nov 2024 Sleep apnea: biotechs snore points in the therapeutic space …the latest biotech news! By clicking this I agree to receive Labiotech’s newsletter and understand that my personal data will be processed according to the Privacy Policy.* Company name* Job… November 13, 2024 - 10 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
More News! 8 Dec 2022 Enhertu’s positive results demonstrate improvement in overall survival …or pneumonitis events were low grade (grade 1 or grade 2) with two grade 3 events and no grade 4 or grade 5 events observed in patients treated with Enhertu…. December 8, 2022 - 4 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
News and Trends 8 Sep 2022 Lutris Pharma radiation trial brings positive results for breast cancer patients …12 weeks and the data showed that LUT014 was generally well tolerated, no severe or serious adverse events occurred and no adverse events were associated with discontinuation of the study… September 8, 2022 - 4 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
News and Trends 6 Jun 2023 Head and neck cancer data presented at ASCO 2023 …and ISA101b was generally well tolerated with a safety profile resembling that of anti-PD-1 monotherapy. There were two grade 3 adverse events related to ISA101b. Grade 4-5 events related to… June 6, 2023 - 7 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email